je.st
news
Home
› US Nonprofit Awards Italian Biotech Additional Funding To Study New Class Of Drugs To Treat Alzheimer's Disease
US Nonprofit Awards Italian Biotech Additional Funding To Study New Class Of Drugs To Treat Alzheimer's Disease
2014-12-29 01:50:16| drugdiscoveryonline Home Page
The Alzheimer's Drug Discovery Foundation (ADDF) and Italian biotechnology company Axxam SpA (Axxam) announced today that the ADDF has awarded a follow-on grant to Axxam to further develop small molecule drugs to treat Alzheimer's disease by targeting inflammation
Tags: additional
class
study
awards
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||